Amgen : AMGN

All Amgen Articles

699 Articles

Jon C. Ogg | Aug 1, 2013 at 8:25 AM EDT

Deutsche Bank Raises Price Targets on Some of Its Top Stocks to Buy

ThinkstockWith the Federal Reserve reminding investors yesterday that it can raise or lower asset purchases in its quantitative easing program…

Paul Ausick | Jul 31, 2013 at 4:25 PM EDT

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Dive to Mixed Close

July 31, 2013: U.S. equity markets opened higher this morning as traders and investors this afternoon’s announcement from the FOMC.…

Paul Ausick | Jul 30, 2013 at 4:07 PM EDT

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

July 30, 2013: U.S. equity markets opened higher this morning as traders and investors wait for tomorrow’s announcement from the…

Jon C. Ogg | Jul 23, 2013 at 8:25 AM EDT

UBS Top Stocks to Buy That Can Beat Earnings Estimates

courtesy of FordThe equity analysts and strategists at UBS A.G. (NYSE: UBS) expect to see U.S. equities continue to conform…

Jon C. Ogg | Jul 2, 2013 at 8:45 AM EDT

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for…

Paul Ausick | Jul 2, 2013 at 7:35 AM EDT

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…

Paul Ausick | Jul 1, 2013 at 4:03 PM EDT

Closing Bell for Monday on Wall Street: Markets Open Higher, Hold Gains

July 1, 2013: U.S. equity markets opened higher this morning after a blast of economic data from both Asia and…

Paul Ausick | Jul 1, 2013 at 7:35 AM EDT

Onyx Pharma Rejects Amgen, but Will Start Search for a Buyer

ThinkstockCancer-drug developer Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) issued a terse press release yesterday, saying it had “received and rejected” a…

Jon C. Ogg | May 15, 2013 at 8:10 AM EDT

Deutsche Bank Firm on Biotech Stocks to Buy

ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and…

Paul Ausick | May 8, 2013 at 4:05 PM EDT

Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day

U.S. equity markets opened lower this morning on relatively little economic data. In Europe, Germany reported that industrial production rose…

Jon C. Ogg | May 6, 2013 at 10:45 AM EDT

The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion

ThinkstockThe world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating…

Paul Ausick | May 1, 2013 at 4:08 PM EDT

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

U.S. equity markets opened lower this morning following a weaker-than-expected employment report from ADP and concern that Friday’s report from…

Jon C. Ogg | May 1, 2013 at 10:45 AM EDT

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Jon OggBiotech stocks come and go as far as the flavor of the day for investors. While many of these…

Jon C. Ogg | May 1, 2013 at 8:15 AM EDT

Top Wall Street Analyst Upgrades: Amgen, Buffett, Dunkin and More

Investors and traders are always on the lookout for fresh research ideas from Wall Street that will lead to higher…

Paul Ausick | Apr 30, 2013 at 10:30 AM EDT

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

ThinkstockDrug giant Pfizer Inc. (NYSE: PFE) this morning reported adjusted earnings and revenues that missed analysts estimates, and the stock…

1 … 31 32 33 34 35 … 47

Amgen : AMGN

All Amgen Articles

Deutsche Bank Raises Price Targets on Some of Its Top Stocks to Buy

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Dive to Mixed Close

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

UBS Top Stocks to Buy That Can Beat Earnings Estimates

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Closing Bell for Monday on Wall Street: Markets Open Higher, Hold Gains

Onyx Pharma Rejects Amgen, but Will Start Search for a Buyer

Deutsche Bank Firm on Biotech Stocks to Buy

Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day

The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Top Wall Street Analyst Upgrades: Amgen, Buffett, Dunkin and More

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Amgen : AMGN

All Amgen Articles

Deutsche Bank Raises Price Targets on Some of Its Top Stocks to Buy

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Dive to Mixed Close

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

UBS Top Stocks to Buy That Can Beat Earnings Estimates

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Closing Bell for Monday on Wall Street: Markets Open Higher, Hold Gains

Onyx Pharma Rejects Amgen, but Will Start Search for a Buyer

Deutsche Bank Firm on Biotech Stocks to Buy

Closing Bell for Wednesday on Wall Street: Markets Open Lower, Stock Prices Rise All Day

The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion

24/7 Wall St. Closing Bell — Wednesday: Markets Cannot Shake-off Low Open and Sink to Close

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Top Wall Street Analyst Upgrades: Amgen, Buffett, Dunkin and More

Pfizer Earnings Miss Follows Amgen: Is Merck Next?

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%